chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included: Covid-19 early on and got over it. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced got the latest variant/Covid-19. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of got the latest variant/Covid-19 was not reported. This report was non-serious. This case, from the same reporter is linked to 20220215108.
Recieved inj. at my PCP office by an MA at approx. 2:30 PM. by 6:30 pm started having twingy shoulder pains.  By 7:00 excruciating pain and unable to move left arm without lifting with other hand.  I took 2 aleve's nothing, put a heating pad around shoulder. no relief.  could not get comfortable at all.  Husband arrived home from work @ 2:00 am and immediately to me to the ER.  Once admitted the Dr. stated that if a vaccine is injected incorrectly too high on the arm, (Which mine was very high).  The vaccine ends up entering the joint.  The antibodies in the vaccine have a reaction to your body that it's an infection.  They explained the IV meds they would be administering and doing shoulder xrays.  I was sent home with a sling, , anti-inflamatory ,medrol dose pak, cephalexin , oxycodone and Bactrim DS.  (for 7 Days) The first day, I did rest and sleep.  Taking the pain meds only the 1st day, but all others the entire 7 days, I was feeling much better and the pain was mild.  Now by 2 days after medication all gone.  I have consistent shoulder pain with arm movement.
Optical nerve was swollen and Nerve was pushing inward; Had blindness in her left eye at 80 percent; A shadow at the top of her left eye; This spontaneous case was reported by a non-health professional and describes the occurrence of BLINDNESS (Had blindness in her left eye at 80 percent) and PAPILLOEDEMA (Optical nerve was swollen and Nerve was pushing inward) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced VITREOUS FLOATERS (A shadow at the top of her left eye). On 21-Apr-2021, the patient experienced BLINDNESS (Had blindness in her left eye at 80 percent) (seriousness criterion medically significant). On 10-May-2021, the patient experienced PAPILLOEDEMA (Optical nerve was swollen and Nerve was pushing inward) (seriousness criterion medically significant). At the time of the report, BLINDNESS (Had blindness in her left eye at 80 percent), PAPILLOEDEMA (Optical nerve was swollen and Nerve was pushing inward) and VITREOUS FLOATERS (A shadow at the top of her left eye) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Patient's husband stated "two days after his wife received the Moderna vaccine she had noticed a shadow at the top of her left eye. Patient stated a week later she had blindness in her left eye at 80 percent. His wife had seen an eye specialist and was told that her optical nerve was swollen and the nerve was pushing inward which was causing the snowy vision. Patient stated his wife cholesterol was 245. Patient's husband  stated his wife had blood work (results not provided) and 2 magnetic resonance imaging tests done (results not provided), on 10-May-2021.  She was seen at institute for the events.   Treatment medications was not provided.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Very limited information has been provided at this time. Further information has been requested.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Patient demographics were added and event added.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, Very limited information has been provided at this time. Further information has been requested.
Developed fever up to 104 after receiving FluMist also developed cough, vomiting and petecial rash.  1/26/07 Received medical records from hospital for 12/15/-12/17/06 admit which reveal patient experienced fever, emesis & petechial rash.  Temp max 104.  Treated w/antibiotics. & d/c to home on additional oral antibiotics. FINAL DX: right otitis media; otitis externa; bronchitis; & viral illness.
Patient reports developing a mild headache post vaccination within 15minutes that progressed in severity with nausea, dizziness and fainting. Occupational Health is following up with patient and recommending comprehensive provider evaluation
sore arm; Small rash; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and RASH (Small rash) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and RASH (Small rash). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown and RASH (Small rash) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Information has been received regarding 2 males who both experienced injection site soreness, swelling and injection site rash. Unspecified medical attention was sought.
next morning weak-sick-that evening during nite diarrhea & vomiting about 5x-morning very weak-no fever-body aches;
Less than 5 minutes after receiving the Pfizer Covid 19 vaccine, the patient slumped to the side hitting his head on the wall.  He started to seize.  His father moved him down to the ground.  He came to and opened his eyes.  His lips were pale and he said he didn't feel well.  His father kept talking to him to keep him awake. The father stated he had seizures in the past.  911 was called and an EpiPen was given.  Paramedics arrived.  The patient was able to walk to the gurney.  Paramedics took him away.
Patient received vaccines listed above around 06:15pm. She states she started chilling around 09:30pm. She states around 11:30 pm her stomach was hurting and to up to take some medication. She then passed out and her husband found her passed out in the floor. He then took her to the emergency room. She states the ER doctor examined her with no significant findings.
Information has been received from a woman in a doctor's office concerning a 5 year old female with no past medical history and no known allergies who on 11/04/1997 was vaccinated with a second dose of varicella virus vaccine live. There was no concomitant medication. On 02/11/2002 the pt developed 19 pox scattered all over her body but mostly on her chest and back. The pt's oral temperature was 98.3 deg F and she had no respiratory involvement. The pt was treated with Beandryl prn. It was reported that the pt recovered. It was also noted that the pt had no known adverse events following previous vaccinations. No further info is expected.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:. The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), on 04Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 1), administration date: 26Apr2021, for COVID-19 immunization; BNT162b2 (Dose: 2), administration date: 10May2021, for COVID-19 immunization. The following information was reported: FATIGUE (non-serious), outcome "not recovered"; FEELING ABNORMAL (non-serious), outcome "not recovered", described as "brain fog"; MYALGIA (non-serious), outcome "unknown", described as "muscle soreness"; BEDRIDDEN (non-serious), outcome "unknown", described as "I was in bed for a few days"; WEIGHT INCREASED (non-serious), outcome "unknown", described as "gained weight"; MENTAL DISORDER (non-serious), outcome "unknown", described as "struggling with my mental health and feeling motivated". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Patients 1st injection: 26Apr2021 At a nursing home. 2nd injection: 10May2021 at a pharmacy. Both were Pfizer injections. Patients 3rd dose of a booster was on 04Dec2021 at a doctor's office. This was also a Pfizer injection. Patient got COVID in mid-May2022. The biggest things patient dealt with during that time were fatigue, brain fog, and muscle soreness. Patient was in bed for a few days. Since then, patient still experience fatigue and brain fog and my anti-depressants stopped working. Patient gained weight. It isn't fun and I've been struggling with patients mental health and feeling motivated. Patient stated, I'm not taking any more boosters from anyone until you all figure this out. I see how pharma is making more money by requiring more injections. But I'm not taking any additional injections from Pfizer or any other company until we know that they are both safe for humans long term and effective long term-effective as in preventing getting COVID completely, and suffering from it's symptoms. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Father called states child received immunization on 06/01/07. Stated child has been running fever since then and has knots and redness around needles sites.
Full body muscle ache (lasted 24-48 hours) Fatigue (lasted 24-48 hours)
2 days following IM injection of 0.5 ml pneumococcal vaccine in the right deltoid muscle, patient returned to clinic with c/o rash to upper chest area and erythema and swelling in lower right arm.  Examined by MD and treated as allergic reaction with po Benadryl.  Follow up appointment scheduled in 2 weeks.
Patient first developed severe headache, chills, myalgia; on 4/2/2018. By 4/11/2018 he had right lower abdominal pain and rash around the same area to his lower right back. Was diagnosed and treated for shingles.
Approximately 15 minutes after vaccination, patient began complaining of chest pain,  throat tightness and nausea.  Patient was administer oxygen to assist with breathing.  Patient's vital signs were stable.  Facility called emergency and patient was transferred to ED for precautionary measures
Pronounced dead on 3/9/21 approximately 72 hours after receiving vaccination. Unknown symptoms prior.
After a couple of days - pt. experienced redness and itching on the right arm - injection site. She went to PCP on 1/5/17 and he said it was infected.
pt recvd vax & devel generalized macular exanthem on entire body; including palms & soles; no other sxs;
3 hrs p/crying but next day pt started thrashing around & screaming; Parents unable to comfort lasted all day;
body aches; chills; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (body aches), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache). At the time of the report, MYALGIA (body aches), CHILLS (chills), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.            No treatment and concomitant medications were provided. The patient was having body aches, chills, fever and headache.
2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic and Hypertensive.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine). On 18-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose after 42 days of 1st shot of Moderna Covid-19 Vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.         Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medications were reported. Treatment information was unknown.   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow-up information received on 24-MAR-2021, contains non-significant information (reporter's Address).
ER visit on 11/15 with Large extension of swelling and subtle erytema to injection site and to almost entire left arm and upper left chest and left trapezius area 2 days after Moderna vaccine booster. significant axillary lymphadenopathy as well.
Vaccine injury from COVID vaccine.; This is a spontaneous report received from a non-contactable reporter (Consumer) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ADVERSE EVENT FOLLOWING IMMUNISATION (medically significant), outcome "unknown", described as "Vaccine injury from COVID vaccine.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
hearing loss; other zoster-related conditions; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient (pt) of unknown gender  whose age at vaccination was 65 years old. No information was provided regarding the pt's medical history, allergies, drug reactions, concurrent conditions or concomitant medications. On 16-JAN-2014, the pt was administered zoster vaccine live (ZOSTAVAX) by the pharmacist at a pharmacy (dose, route of administration, anatomical location, lot # and expiration date were not reported) for the long-term prevention of shingles and zoster-related conditions. Subsequently, on an unknown date, the pt was treated by a physician for the following injuries resulting from the pt's zoster vaccine live (ZOSTAVAX) use: hearing loss and other zoster-related conditions. The outcome of the events was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, the event of hearing loss was determined to be medically significant.
a red lesion developed on vaccinated arm and rash developed after that. At times rash was itchy. Currently 3 days of lesion and rash.
major fatigue; headache; nausea; vomit; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (vomit), FATIGUE (major fatigue), HEADACHE (headache) and NAUSEA (nausea) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced VOMITING (vomit) and NAUSEA (nausea). On an unknown date, the patient experienced FATIGUE (major fatigue) and HEADACHE (headache). On 19-Jan-2021, VOMITING (vomit) and NAUSEA (nausea) had resolved. At the time of the report, FATIGUE (major fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
large knot right above the injection site/size of a half dollar/size of a silver dollar and where the needle went in was right at the base of that knot/like egg under the skin or clot; felt like she got a flu shot and could tell her arm was very sore; swelling started almost immediately after the shot/swelling was exactly underneath the injection site, just in the pronounced area/about 4 inches wide and about 2 inches high; thought maybe someone has hit a vein because it did bleed and ran down her arm; This is a spontaneous report from a contactable consumer.  A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EN6201, unknown expiration), via an unspecified route of administration on 18Feb2021 at 04:30 at a single dose for COVID-19 immunization. Medical history reported as none. Concomitant medications included tolterodine and adalimumab (HUMIRA). The patient reported that she received the COVID vaccine on 18Feb2021 at around 4:30. Firstly it was fine, she felt like she got a flu shot and could tell her arm was very sore. What concerned her was the swelling started almost immediately after the shot on 18Feb2021. She knew that was one of the symptoms. This morning and yesterday though (18Feb2021), she noticed some of the symptoms. She got a large knot that was right above the injection site. Yesterday, it was about the size of a half dollar, today it is about the size of a silver dollar and where the needle went in was right at the base of that knot. It feels like an egg under the skin or a clot. Like a knot (a hard spot underneath the skin). The patient was wondering if it was something she should be concerned about because the swelling was exactly underneath the injection site, just in the pronounced area. It was a rectangle and is about 4 inches wide and about 2 inches high and then right above that was where the needle went in. The large circle or knot was right above that and she was thinking possibly when she was given the injection she has never really bleed before. So, she thought maybe someone has hit a vein because it did bleed and ran down her arm. She got no problem. That happens at times, but she started thinking if this was a clot or it was something that is right above there because it is so pronounced, and it really hurts. The patient stated that she took some Aspirin last night and is going to take an ibuprofen in a little while. She mentioned that she takes this one pill and it has nothing to do with anything.  The patient had lab work done (unknown results) that was about 3 weeks ago (2021). She also stated that she also take Humira which is a shot every 2 weeks and it said in the fact sheet that she should be concerned or be sure that she did not take any medicine that affects the immune system and Humira does weaken the immune system but she was not ask that prior to. The patient wanted to know if is that something she should be concerned about. Outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a 59 year old male patient referring to himself.  Concomitant medications included an unspecified high blood pressure medication.  He had no history of drug/reactions/allergies.  He stated he has been a carrier for herpes simplex I for an unspecified amount of time.  On 29-NOV-2016, the patient received ZOSTAVAX subcutaneously for herpes simplex virus prevention (lot number not provided).  An unspecified time later, he experienced lip swelling and fever blisters in his mouth.  He also reported he subsequently transmitted the herpes simplex I virus to his girlfriend.  He went to Urgent Care on an unspecified date and was given a steroid.  The patient receovered from the events.  The patient requested reimbursement for the ZOSTAVAX or he would contact his lawyer. Additional information has been requested.
102 degree Fever that lasted 27 hours total. Total symptoms included fever, body aches, chills, and loss of appetite Same thing happened with the first dose. I had previously had severe case of covid in March 2020.
PT GOT MILD HIVES ON BOTH LEGS, PT ALREADY PUT ON SOME HYDROCORTISONE BUT STILL ITCHY. PATIENT SAID SHE IS DOING OK AND NOT TOO CONCERN ABOUT IT.   PT ALREADY CONTACTED HER PROVIDER AND WAITING FOR A CALL BACK.
My arm swelled and it was hot and hard. I also had a rash torso, chest arms and neck. It lasted for over a week.
Within 2 hours of H1N1 injection became nauseated and started vomiting. Lasted 24 hours. Mass clinic was 12/5/09.
Information has been received from a physician concerning to a retired physician who on an unspecified date was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot number not reported). The reporting physician mentioned that on an unspecified date he believed the patient had developed a case of shingles after receiving ZOSTAVAX (Merck). At the time of the report, the patient's outcome was unknown. This is one of two reports received from the same source. Additional information has been requested.
difficulty breathing, irregular heart beat, very weak, very tired; sx occured p/taking the 1st dose;
I had a palm sized very itchy, dry, uncomfortable  area show up on my left quad that spread to be approximately 5 inches in diameter.  I also had a similar, smaller patch on my abdomen about the size of a quarter. The abdomen patch went away. The patch on my quad continued and flared up again in June. I used betamethasone steroid cream to clear it up. I also had an unrelated issue of small itchy, burning red bumps on my hands and feet that appeared in June when this same patch flared up.  I used ice packs to cool these and took anti-histamine even though I had no evidence of any allergic reaction or exposure to anything new in my environment.
About 10 hours after the shot, I started feeling tired and achy.  Went to bed and 1-2 hours later I started to feel nauseous and began vomiting.  Continued for 3-4 hours.  Woke up in the morning feeling like I?ve been hit by a bus and wanted to sleep.  Woke up around 3:00 pm that day and started to feel better.  By the next day all symptoms were gone and I felt fine.
Dose of Pediarix vaccine was given on 10/18/05. Drug expiration was 10/15/05.
Presented w/ SOB, cough, weakness X1 wk. Tx for covid+ pneumonia w/ Dexamethasone, Zinc, IV, Remdesivir, O2
event began within hours of injection;  ongoing event as of today - upper arm sore, red area - 3" diameter, advil for pain